Sotagliflozin: Expanding Horizons Beyond Glycemic Control and Cardiovascular Protection in Type 2 Diabetes
Sotagliflozin: Expanding Horizons Beyond Glycemic Control and Cardiovascular Protection in Type 2 Diabetes Many thanks to our sponsor Esdebe who helped us prepare this research report. Abstract Sotagliflozin, a dual sodium-glucose cotransporter 1 and 2 […]
